Back
47
Day Range
$227.57
$231.77
52-Week Range
$199.92
$293.81
Volume
685,022
50D / 200D Avg
$252.88
/
$260.16
Prev Close
$225.99
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 23.8 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 27.2 | 3.9 |
| Rev Growth 5Y % | 12.6 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$295.88
+29.8%
Low: $265.00
High: $345.00
Forward P/E
20.6
Forward EPS
$11.05
EPS Growth (est.)
+0.0%
Est. Revenue
5.6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$16.20
$15.91 – $16.44
|
7.8 B | 4 |
| FY2029 |
$14.38
$14.13 – $14.59
|
7 B | 3 |
| FY2028 |
$13.43
$12.12 – $14.29
|
6.5 B | 9 |
Key Takeaways
Revenue grew 12.64% annually over 5 years — strong growth
Earnings grew 37.20% over the past year
Net margin of 27.22% shows strong profitability
Generating 1.66B in free cash flow
PEG of 0.72 suggests growth is underpriced
Cash machine — converts 118.63% of earnings into free cash flow
Growth
Revenue Growth (5Y)
12.64%
Revenue (1Y)9.84%
Earnings (1Y)37.20%
FCF Growth (3Y)72.37%
Quality
Return on Equity
N/A
ROICN/A
Net Margin27.22%
Op. Margin32.75%
Safety
Debt / Equity
N/A
Current RatioN/A
Interest Coverage133.66
Valuation
P/E Ratio
23.76
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9.84% | Revenue Growth (3Y) | 10.39% |
| Earnings Growth (1Y) | 37.20% | Earnings Growth (3Y) | 24.92% |
| Revenue Growth (5Y) | 12.64% | Earnings Growth (5Y) | 31.08% |
| Profitability | |||
| Revenue (TTM) | 5.15B | Net Income (TTM) | 1.40B |
| ROE | N/A | ROA | N/A |
| Gross Margin | 59.36% | Operating Margin | 32.75% |
| Net Margin | 27.22% | Free Cash Flow (TTM) | 1.66B |
| ROIC | N/A | FCF Growth (3Y) | 72.37% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | 133.66 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 23.76 | P/B Ratio | N/A |
| P/S Ratio | 6.47 | PEG Ratio | 0.72 |
| EV/EBITDA | N/A | Dividend Yield | 0.01% |
| Market Cap | 33.28B | Enterprise Value | N/A |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.15B | 4.69B | 4.22B | 3.58B | 3.20B |
| Net Income | 1.40B | 1.02B | 897.56M | 779.44M | 474.51M |
| EPS (Diluted) | 9.51 | 6.92 | 6.09 | 5.30 | 3.24 |
| Gross Profit | 3.05B | 2.66B | 2.36B | 2.02B | 1.84B |
| Operating Income | 1.69B | 1.32B | 1.13B | 1.00B | 903.68M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#199 of 326
Recent Activity
Entered
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026